# Ali Ahmed

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ali-ahmed/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,125 |
| Field | Heart Failure Treatment and Management |
| h-index | 68 |
| i10-index | 273 |
| Last Known Institution | Linköping University |
| OpenAlex ID | https://openalex.org/A5100367160 |
| ORCID iD | 0000-0002-6832-6424 |
| Works | 710 |

## Researcher papers

- [Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study](https://scholariq.org/papers/clinical-presentation-aetiology-and-outcome-of-infective-endocarditis-results-of/)
- [Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States](https://scholariq.org/papers/trends-in-incidence-management-and-outcomes-of-cardiogenic-shock-complicating-st/)
- [Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure](https://scholariq.org/papers/effects-of-digoxin-on-morbidity-and-mortality-in-diastolic-heart-failure/)
- [Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods](https://scholariq.org/papers/heart-failure-chronic-diuretic-use-and-increase-in-mortality-and-hospitalization/)
- [Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial](https://scholariq.org/papers/digoxin-and-reduction-in-mortality-and-hospitalization-in-heart-failure-a/)
- [Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study](https://scholariq.org/papers/temporal-trends-in-incidence-and-outcomes-of-peripartum-cardiomyopathy-in-the/)
- [Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure](https://scholariq.org/papers/effects-of-right-ventricular-ejection-fraction-on-outcomes-in-chronic-systolic/)
- [Developing Therapies for Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/developing-therapies-for-heart-failure-with-preserved-ejection-fraction/)
- [Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials](https://scholariq.org/papers/effects-of-quercetin-on-blood-pressure-a-systematic-review-and-meta-analysis-of/)
- [Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study](https://scholariq.org/papers/effect-of-covid-19-pandemic-lockdowns-on-planned-cancer-surgery-for-15-tumour/)
- [Effectiveness of Digoxin in Reducing One-Year Mortality in Chronic Heart Failure in the Digitalis Investigation Group Trial](https://scholariq.org/papers/effectiveness-of-digoxin-in-reducing-one-year-mortality-in-chronic-heart-failure/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [Linköping University](https://scholariq.org/institutions/linkoping-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.